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Abstract: While natural intoxications with seeds of Ricinus communis (R. communis) have long been
known, the toxic protein ricin contained in the seeds is of major concern since it attracts attention
of those intending criminal, terroristic and military misuse. In order to harmonize detection
capabilities in expert laboratories, an international proficiency test was organized that aimed at
identifying good analytical practices (qualitative measurements) and determining a consensus
concentration on a highly pure ricin reference material (quantitative measurements). Sample
materials included highly pure ricin as well as the related R. communis agglutinin (RCA120) spiked
into buffer, milk and meat extract; additionally, an organic fertilizer naturally contaminated with
R. communis shred was investigated in the proficiency test. The qualitative results showed that
either a suitable combination of immunological, mass spectrometry (MS)-based and functional
approaches or sophisticated MS-based approaches alone successfully allowed the detection and
identification of ricin in all samples. In terms of quantification, it was possible to determine a
consensus concentration of the highly pure ricin reference material. The results provide a basis for
further steps in quality assurance and improve biopreparedness in expert laboratories worldwide.
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1. Introduction
The plant toxin ricin produced by Ricinus communis (R. communis) has been intensively studied
since its identification in 1888 by Stillmark [1]. Ricin is a prototype AB toxin of approximately
60 kDa consisting of a catalytically active A-chain (~32 kDa) which acts as an RNA N-glycosidase
and a sugar-binding B-chain (lectin, ~34 kDa) linked via a disulfide bond [2,3]. Cell binding occurs
through the B-chain and involves different oligosaccharide residues on the cell surface. Several
oligosaccharide residues, including N-acetylglucosamine and galactose residues on glycolipids and
glycoproteins, are known receptors for the lectin subunit, and these oligosaccharides show a broad
and abundant presence on mammalian cells [4–6]. The study of ricin (RCA60) was complicated by
the presence of a homologous protein in the seeds of R. communis identified as Ricinus communis
agglutinin (RCA120), a much less toxic dimeric protein with high sequence identity to ricin. Whereas
ricin is a monomeric AB toxin, R. communis agglutinin is a ~120 kDa dimer of two A- (~32 kDa) and
B-subunits (~36 kDa) [7] in which the two A-chains are linked by a disulfide bond [8]. The amino
acid sequences of the A- and the B-chains of RCA60 and RCA120 show a high degree of homology of
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94% and 85%, respectively [9]. This reflects their similar but not identical structures and biochemical
properties [10,11]. Adding further complexity to the issue, an isoform of ricin named ricin E (while
the original ricin is now termed ricin D) was later discovered both on protein and on DNA levels to
contain a hybrid B-chain of ricin and R. communis agglutinin [12–14].
Recently, sequence analysis methods have revealed that ricin and R. communis agglutinin are
members of a ricin gene family encoding seven full-length ricin or ricin-like proteins and several
potential shorter gene products of unknown expression and function, reflecting a much greater
variability as previously anticipated [15,16]. The full-length proteins of the ricin gene family have
been shown to inhibit protein synthesis similar to ricin itself [16]. Additional heterogeneity of ricin
is based on different glycosylation patterns [17] and variable toxicities of ricin isoforms have been
correlated with different glycosylation levels [18,19]. Another level of complexity has recently been
added by the description of heterogeneity in the deamidation pattern, the conversion rate of single
asparagine residues to aspartic and isoaspartic acid [20].
Ricin and the ricin-producing plant are recognized as dual-use substances: On the positive side,
R. communis is of economic interest for the production of castor oil and the numerous industrial,
medical and cosmetic products derived from it [3,21]. Castor oil contains high levels of the unusual
fatty acid, ricinoleic acid, which is rewarded for its unique chemical properties used in the production
of lubricants, pharmaceuticals, paints, coatings, inks and other products. Furthermore, the ability
of the A-subunit to induce cell death has been exploited for the development of immunotoxins
and medical application [3,22,23]. The catalytic A-chain of ricin was one of the first examples of
a toxin coupled to monoclonal antibodies against cell surface proteins and tested experimentally
for the treatment of various cancers [3,24–27]. On the negative side, ricin has a history of military,
criminal, and terroristic misuse. It was included in different weapons programmes during World
War II under the codename “compound W”, and weaponized material was later produced until
the 1980s [3,28–31]. Therefore, ricin is a prohibited substance both under the Chemical Weapons
Convention (CWC, schedule 1 compound) and the Biological Weapons Convention (BWC) and its
possession or purification is strictly regulated and controlled by the Organization for the Prohibition
of Chemical Weapons (OPCW) [3]. The relative ease in preparing a crude extract and the world-wide
availability of the plant has also made ricin a potential agent of bioterrorism, therefore it is
listed as category B agent of potential bioterrorism risk by the Centers for Disease Control and
Prevention [3,32,33]. In the past, the focus fell on the toxin for criminal misuse and various attempted
acts of bioterrorism; for example, the “ricin threat letters” sent in 2003 and 2013 to members of the US
Senate and the White House as well as to U.S. President Obama gained broad media coverage [28,34].
Due to the toxin’s potential for misuse, the rapid, sensitive and ideally unambiguous detection
of ricin is necessary. A range of different detection methods are available using immunological,
spectrometric, functional or molecular approaches [3]. Antibody-based immunoassays such as
enzyme-linked immunosorbent assays (ELISAs) belong to the most sensitive routine technologies
with detection limits between a few ng/mL and fg/mL depending on the antibodies used [35–41].
Since classical ELISAs require several hours for analysis fast on-site detection systems such as
hand-held lateral flow assays (LFA) [41–43] and automated biosensor technologies have been
developed [44–46] which usually provide results within 30 min down to a few ng/mL of toxin.
Currently, immunological assays are not able to distinguish ricin from the related RCA120, a task
that might be relevant in the course of a forensic investigation. In this context, modern mass
spectrometry methods (e.g., Matrix-Assisted Laser Desorption Ionization—Time of Flight mass
spectrometry (MALDI-TOF MS) and liquid chromatography-electrospray ionization-tandem mass
spectrometry (LC-ESI MS)) are able to deliver unambiguous sequence information from pure
and crude toxin preparations, and sensitivities can reach down to a few ng/mL of toxin when
a combination of immunoaffinity- or lectin-based enrichment, tryptic digestion plus MS-based
detection and identification of specific peptides is applied [47–53]. Additionally, different functional
approaches have been introduced which detect the A-chain activity (e.g., adenine-release assays, cell
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free translation assays [54–61], the B-chain activity (e.g., enzyme-linked lectin assays [62]) or both
(e.g., cell-based cytotoxicity assays [60,63–66]). Current cell-based assays use different endpoint
read-outs of cell death via biochemical, fluorescent or radioactive detection [63–66] or, alternatively,
display the cytotoxic activity of ricin in real-time based on impedance measurement [60]. The
detection limits for ricin analysis in cell-based bioassays have been described as being between
0.01 ng/mL and 0.8 ng/mL from complex matrices. Alternatives include assays where an antibody-based
enrichment is combined with adenine release measurement by mass spectrometry [51,67,68].
While different technologies for ricin detection and identification have been established, no
universally agreed “gold standards” are available. Expert laboratories currently use differently
purified in-house reference materials for quantification, making any comparison of accuracy and
sensitivity of different methods nearly impossible. The aim of the proficiency test (PT) on ricin
organized in the framework of the EU-project EQuATox (Establishment of quality assurance for
the detection of biological toxins of potential bioterrorism risk, www.equatox.eu; funded under
the European Community’s Seventh Framework Programme) was to provide an overview and
evaluation of existing methods for screening and identification of ricin. Herein we describe selected
qualitative and quantitative PT results obtained by 17 international expert laboratories from 12
countries. The results highlight “best practices” for the analysis of ricin and are an important step
towards harmonization and standardization of analytical methods.
2. Results and Discussion
2.1. Preparation of the Ricin Proficiency Test
To set up a proper PT test plan, nine samples were selected for further preparatory analysis
taking into account the following (Table 1):
(i) The samples needed to be detectable with a range of different techniques, as the PT was open with
respect to the methods applied by the participants. The expectation of a technically open PT was
to obtain information on best analytical practices. To this end, three different concentrations of
highly purified ricin (prepared and characterized in [69]) in buffer containing a stabilizing protein
were selected: a high (500,000 ng/mL), an intermediate (500 ng/mL) and a low (0.5 ng/mL)
concentration of purified ricin in PBS/0.1% BSA.
(ii) For the analyses of the influence of complex matrices on the detection of ricin, the intermediate
concentration of ricin (500 ng/mL) was spiked into semi-skimmed milk and a particle-free, sterile
extract of minced meat.
(iii) To obtain information on the specificity of different methods, the highly homologous RCA120
was selected (prepared and characterized in [69]). Equivalent concentrations of RCA120 and ricin
(500,000 ng/mL and 500 ng/mL) were spiked into buffered solutions (PBS/0.1% BSA).
(iv) Finally, as “real sample”, a commercially available organic fertilizer containing R. communis
shred was used that caused a case of dog poisoning in Germany [3]. This material represented
a naturally contaminated sample containing unknown concentrations of ricin, RCA120 and
the alkaloid ricinine. According to the manufacturer the fertilizer was enriched with a crude
R. communis preparation, the press-cake of an industrial castor oil extraction process that is often
used as additive in fertilizer as a rich source of nitrogen. The sample was included in the PT to
evaluate the laboratories’ sample preparation strategies.
The PT samples, as depicted in Table 1, were further analyzed by stability testing. According
to Thompson et al. and ISO/IEC 17043:2012, samples have to be sufficiently stable during the
predefined testing period which was set to four weeks by the PT organizer [70,71]. Stability testing
was performed by two sandwich ELISAs detecting ricin or RCA120 [69], using ten aliquots of each
of the nine samples depicted in Table 1. Five aliquots were stored at ´80 ˝C for four weeks, and for
comparison five aliquots were stored at 4 ˝C for four weeks, the latter representing the recommended
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storage condition during the PT. All sample sets were analyzed simultaneously by either ricin and/or
RCA120-ELISAs corresponding to the toxin contained in the respective sample.
Table 1. PT test plan.
Samples Selected as Potential PT Samples for Further Stability Testing PT Sample Number
1 Negative sample (=buffer: 0.1% BSA/PBS) S1
2 500,000 ng/mL of ricin in 0.1% BSA/PBS S6
3 500 ng/mL of ricin in 0.1% BSA/PBS S3
4 0.5 ng/mL of ricin in 0.1% BSA/PBS S7
5 500 ng/mL of ricin in semi-skimmed UHT milk S4
6 500 ng/mL of ricin in extract of minced meat S8
7 500,000 ng/mL of RCA120 in 0.1% BSA/PBS S2
8 500 ng/mL of RCA120 in 0.1% BSA/PBS S5
9 Organic fertilizer (solid sample material) S9
As shown in Figure 1, the results indicated that all samples were sufficiently stable over the given
time period of four weeks. This result was confirmed statistically by Dunnett’s tests which showed no
significant deviation in concentrations under these two storage conditions (all p > 0.05; not shown).
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Figure 1. Stability of PT samples as measured by sandwich ELISA. Five replicates of each of the nine
samples were either stored at ´80 ˝C or 4 ˝C for four weeks. Absorbance of samples S1, S3, S4, S6, S7,
S8 and S9 was measured by ricin-ELISA, absorbance of samples S2 and S5 by RCA120-ELISA. Plotted
is the absorbance at 450 nm minus absorbance at the reference wavelength 620 nm against the storage
condition ´80 ˝C or 4 ˝C for four weeks; error bars indicate the standard errors obtained for five
randomly selected sample replicates per storage condition.
Based on the stability study, samples S1 to S9 were selected as suitable PT samples. For the actual
PT, 33 aliquots of each s mple S1 t S9 were prepared as described before. Of these, ten aliquots of
each sample were randomly selected for homogeneity testing. Homogeneity of each test material
was assessed according to Thompson et al. [71] and ISO/IEC 17043:2012 [70] by employing the
corresponding sandwich ELISAs for either ricin or RCA120. Figure 2 graphically displays the results
4990
Toxins 2015, 7, 4987–5010
of the homogeneity tests in which ten aliquots of each sample were measured twice in duplicate
by ELISA. At first glance measured absorbance values indicate sufficient sample homogeneity. It
was noticeable that in some cases the standard deviation of duplicates was larger than the variation
between the two experiments (e.g., S3). Statistically, Cochran tests showed outlying variances in
four samples (one only in each of the four samples) at a significance level of 0.05 (not shown). In
accordance with Recommendation 9 in [71] these variance outliers were excluded from the assessment
of the homogeneity according to Recommendations 7 and 8 in [71]. This assessment proved sufficient
homogeneity for each sample.
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Figure 2. Homogeneity study. Ten randomly selected test portions of each sample (S1–S9) were
analyzed by a sandwich ELISA preferentially detecting ricin or RCA120, respectively, in two
independent experiments (depicted in red and blue), each performed in duplicate. The mean
absorption of each duplicate with its standard error (error bars) is plotted against the ten replicates
of each sample. Absorbance of samples S1, S3, S4, S6, S7, S8 and S9 were measured by ricin-ELISA,
absorbance of samples S2 and S5 by RCA120-ELISA.
Although the highly purified ricin and RCA120 preparations used to spike the PT samples and
thoroughly characterized by Worbs et al. [69] represent well-defined, qualified materials, they are still
not certified as reference materials. According to Thompson et al., in this situation it is necessary to
determine the protein concentration experimentally after spiking the purified toxins into the buffer or
matrix [71]. This provides the “nominal concentration” of the samples as opposed to the “theoretical
concentration” that is the known spiked concentration, assuming there are no losses during sample
preparation, no matrix effects or other disturbing factors.
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Therefore, the ricin- and RCA120-ELISA were used as above to precisely quantify all
nine samples: three randomly selected aliquots of each sample were measured in independent
experiments in duplicate on three consecutive days. The mean absorption values of the duplicates
that lay in the linear range of the standard curve were interpolated in the standard curve to calculate
the concentrations of the samples. The calculated concentrations of the three replicates of each sample
measured on three days were statistically analyzed, and estimates of the nominal concentrations were
obtained with the robust algorithm according to ISO 5725-5:1998 [72] as depicted in Table 2.
Table 2. Proficiency test: sample identity and statistics. Nominal concentrations are highlighted
in bold. Consensus mean concentrations based on the participants’ reported results used as xa are
highlighted in green.
Sample Matrix Measurand c(Theoretical) * c(Nominal) ** σ(rob) xa σp Unit
S1 0.1% BSA/PBS - - - - - - -
S2 0.1% BSA/PBS RCA120 500,000 572,851 62,686 563,994 143,876 ng/mL
S3 0.1% BSA/PBS Ricin 500 504 110 522 133 ng/mL
S4 skimmed milk Ricin 500 473 96.3 436 111 ng/mL
S5 0.1% BSA/PBS RCA120 500 445 65.2 481 123 ng/mL
S6 0.1% BSA/PBS Ricin 500,000 589,508 78,055 588,949 150,242 ng/mL
S7 0.1% BSA/PBS Ricin 0.5 0.414 0.112 0.441 0.112 ng/mL
S8 meat extract Ricin 500 484 111 508 130 ng/mL
S9 Organic fertilizer RCA120 - 42 5.818 42 52.6 µg/gRicin - 306 71.6 206 10.7 µg/g
* The “theoretical concentration” was the known concentration of ricin or RCA120 that was spiked into the
different matrices. Sample S9 was a naturally contaminated material, the true “theoretical values” were not
known. ** Robust estimates of mean nominal concentrations as determined experimentally by the organizing
laboratory by ELISA for ricin or RCA120, respectively. σ(rob): robust estimate of the standard deviation of the
nominal concentrations. xa: assigned value σp: standard deviation for proficiency assessment.
Additionally, for the subsequent quantitative analysis of PT results reported by the participants,
the assigned values xa for the nine samples were defined according to the following decision rule:
the consensus mean based on the participants’ reported results was used as xa if the absolute
difference between the nominal value determined in the organizer’s laboratory and the mean of the
participants’ responses was not larger than 50% of the nominal value given in Table 2 (this was the
case for all but one quantitative measurement); otherwise the nominal value was used. Based on
xa the standard deviation for proficiency assessment, σp, was calculated assuming a normal variate
0.95 confidence interval of (xa ´ 0.5¨ xa; xa + 0.5¨ xa) (corresponding to a reproducibility limit of 0.5¨ xa),
i.e., σp = 0.5¨ xa/1.96 = xa/3.92 (Table 2). As there are no “true” values or certified reference materials
available, this was the choice made on the basis of the rule that inter-laboratory reproducibility limits
are very often about twice the repeatability limits. The latter was assumed to be about 25% of the
concentration, as was supported later by the experience in this PT. Table 2 summarizes the theoretical
concentration for each sample, the robust estimate of the mean nominal concentration based on the
experiments performed in the organizer’s laboratory, the robust estimate of the standard deviation of
the nominal concentrations as well as the assigned values and the standard deviation for proficiency
assessment for each sample and measurand.
For samples S1–S8 the theoretical concentration was known, and the experimentally determined
nominal concentrations ended up closely to the expected theoretical concentration. The only
exception was sample S9, the organic fertilizer, a real sample material, where no theoretical values
for ricin and RCA120 concentration were known.
Determination of the nominal concentrations of the nine samples concluded the preparatory
experimental part of the ricin PT. With respect to shipment of active toxin-containing samples and
depending on the destination of the shipment, an OPCW notification as well as different individual
authorizations were required and obtained by the national authorities of the participating countries,
e.g., clearance certificates and import or export permits. The actual shipment was realized using
a dedicated shipper (World Courier, Germany) as security transport: the transport of toxins as a
dangerous goods shipment followed the classification toxic class 6.1, UN3172. The material was
packed in IATA/ADR-approved 4GU boxes (Bio-Bottles, Alex Breuer GmbH, Cologne, Germany),
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and the dispatch of samples from the organizer’s laboratory was done by a certified shipping agent.
The samples were transported in Bio-Bottles securely locked in 20 kg steel containers equipped with
temperature loggers and cooling devices and were tracked throughout the shipment.
Two months before the actual shipment of samples, the interested laboratories obtained an
official announcement letter including a nomination form and information on objectives of the PT, the
test design, the potential sample materials and measurands, a timeline for the PT, basic information
on reporting and analysis as well as comments on the requirements and regulations to be obeyed.
Deadline to deliver results was announced to be four weeks after shipment of samples. 17 expert
laboratories from 12 countries worldwide actively took part in the exercise and received 1.2 mL of
liquid samples S1 to S8 and 10 g of solid sample S9. All samples reached their destination within three
days. The electronically transmitted temperature logging files indicated that all packages arrived at
their destinations at temperatures below 7 ˝C. The participants confirmed that all samples arrived
cooled and in a good condition.
In order to re-confirm sample stability, the organizer’s laboratory measured once again the
concentration in all samples in one randomly selected sample set four weeks after sample shipment
(not shown). The concentrations determined in the post stability test were compared to the nominal
concentrations determined before sending samples to PT participants in the homogeneity study and
confirmed the findings of the pre PT stability studies, i.e., that all samples were sufficiently stable
during the period of the ricin PT.
2.2. Results of the Ricin Proficiency Test
One major goal of the ricin PT was to define good analytical strategies; therefore, the PT was
open with respect to the methods applied by the PT participants. The participants were asked
to deliver their results both qualitatively and/or quantitatively in two technically independent
replicates (including all steps of sample preparation) per method applied, using a dedicated Excel
reporting file. Additionally, since laboratories were free to combine different methods and analytical
approaches, they were asked to fill in a report summarizing their sample-specific conclusions in a final
result sheet, taking into account different results that might have been obtained by applying different
methods. One challenge in this international PT laid in the restricted sample volume provided
(1.2 mL for S1–S8/10 g for S9). If a laboratory was planning to apply both qualitative and quantitative
analysis or to combine different technical approaches the volume per analysis had to be carefully
planned. Qualitative and quantitative results reported by the PT participants were summarized in
anonymized form and selected results will be discussed in the next two sections.
2.2.1. Qualitative Results of the Ricin Proficiency Test
Participants were asked to report their experimental results as “ricin”, “RCA120”, “ricin and/or
RCA120”, “negative result (i.e., nothing detected)” or “not analyzed” in a dedicated Excel workbook.
Qualitative results were assessed according to the degree of trueness of the participant’s assignments
and color codes were used to indicate the assessment (Table 3). Samples S2 to S8 were assessed
as “correct/light green” if results were reported as “ricin and/or RCA120” without differentiation
between ricin and RCA120 taking into account the following consideration: in case of an intentional
release of toxins from Ricinus communis it would be important to detect the material as fast and
reliable as possible in order to take adequate actions. Depending on the scenario, ricin and RCA120
would potentially be found together in the sample material. In a potential biothreat scenario, it is
important to know which methods would be able to detect the threat and to identify “dangerous”
samples, irrespective of the differentiation of the two highly homologous proteins. The differentiation
of ricin and RCA120 is technically challenging, but might be necessary under certain circumstances
(e.g., in the context of OPCW activities or in a case of prosecution). Therefore, if PT participants were
able to differentiate ricin from RCA120 for samples S2 to S8, this result was assigned as “completely
correct/dark green”.
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Table 3. Color code to represent correct assignment of the PT samples.
Completely correct; for samples S2–S8 differentiation of ricin and RCA120
Correct; no differentiation of ricin and RCA120
Partly correct; one of two replicates was correct but not both
Insufficient assignment
Not analyzed
Generally, a variety of methods was applied in the ricin PT, combining different principles
of detection, identification and quantification. Qualitative results reported by the participants on
samples S1–S9 were analyzed by comparison of different technological approaches applied. Since
a number of methods combine different analytical principles (e.g., immunoaffinity enrichment plus
mass spectrometric detection and/or functional testing of ricin’s depurination activity) it was not
easy to form well-defined groups; however, some general conclusions on the methods applied could
be drawn by subdividing into immunological, mass spectrometric and functional methods.
With respect to immunological methods applied within this PT, seven different plate-bound
sandwich ELISA formats based on different antibodies and detection protocols were used, among
them in-house assays and commercial products (Figure 3). Additionally, two immunological
on-site detection methods were applied: (i) six different LFA tests, including commercial products;
and (ii) a commercially available electrical biochip sensor technology (portable Toxin Detector, pTD,
Bruker Daltonik, Billerica, MA, USA; [44]) was used by two laboratories (Figure 4).
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Figure 3 shows that most ELISAs delivered correct results on all nine samples. This was
especially true for ELISA 2, 3, 4 and 7 (marked by an arrow). Flaws occurred on single samples
using ELISA 1, 5 and 6. Notably, the different ELISAs were generally not able to discriminate ricin
from RCA120, corresponding to the light green color code displayed in Figure 3 for samples S2–S8.
On the positive side, the majority of ELISA approaches used were able to correctly identify sample
S7, the sample with lowest concentration (0.441 ng/mL ricin), as ricin-containing material.
The results obtained for the LFAs were more heterogeneous than the ELISA results shown above
(Figure 4). Three laboratories were able to detect eight out of nine samples correctly using LFA 2,
LFA 4 and LFA 5 (marked by an arrow), the only flaw occurred for the sample S7 containing the lowest
concentration, which obviously contained ricin below the detection limits of the assays (usually in
the low ng/mL-range [43,73,74]). Generally, high and intermediate concentrations of ricin in buffer
or complex matrices (S6, S3; S4, S8) were correctly detected by LFA. Some participants misinterpreted
the RCA120-containing samples S2 and S5 as ricin. One commercially available product, LFA 2, was
applied in three participating laboratories. Remarkably, this simple on-site detection test delivered
three different results, possibly due to application or reporting errors in the three laboratories. It
has been observed before that LFAs which are advertised as “easy to use assays” require a basic
level of training and evaluation before reliable results can be obtained [73]. Furthermore, a previous
study reported a significant variability in assay results with different commercial products: in a
direct comparison only three out of six commercial LFAs tested performed well and delivered useful
results [73]. LFA 5, the “BioThreat Alert Test Strip” distributed by Tetracore, USA, used in this
exercise by one laboratory, has been identified before as robust, well-performing assay in independent
laboratories [73,75]. LFA 2 and LFA 4, which performed well upon correct handling in this exercise,
are presented in more detail together with four classical ELISA approaches (Figure 3) in Simon et al.
in this Special Issue of Toxins [42].
In an alternative approach, two participants used the commercial pTD platform, an automated
electrical biochip instrument based on miniaturized, multiplexed sandwich ELISAs performed on
gold electrodes [44]. Similar to the LFA results, eight out of nine samples were correctly detected by
this instrument (marked by an arrow). As with the classical ELISA (Figure 3), both the different LFAs
and the pTD instrument were not able to discriminate ricin from RCA120 (corresponding to color
code light green for S2–S8), which is of minor importance in an acute threat scenario. Nevertheless,
this exercise identified the pTD instrument as well as LFA 2, LFA 4 and LFA 5 as suitable screening
approaches to detect “dangerous”, ricin-containing samples. Further method-performance studies
focusing on selected on-side detection assays applied in this exercise will have to be performed to
obtain a more detailed insight into the general reliability and applicability of the approaches.Toxins 2015, 7 12 
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current MS approaches [51], the detection of sample S7 containing the lowest concentration of ricin 
was unsuccessful in this exercise. Selected successful mass spectrometric methods for the detection 
and identification of ricin are described in more detail by Kalb et al. in this Special Issue of Toxins [76]. 
With respect to functional testing, two different types of functional assays were applied by  
the laboratories: 
(i) a combination of immunoaffinity enrichment plus detection of the depurination activity of 
ricin or RCA120 from an artificial substrate (MS-based adenine release assay); 
(ii) a cell-based cytotoxicity assay detecting the cell death induced by ricin or RCA120. 
As an optional challenge, the PT participants were asked to rank samples S1, S3 and S5 by their 
functional activity using the designation “highest”, “intermediate” and “lowest” functional activity. 
Therefore, functional assays were preferentially used on samples S1, S3 and S5 in order to work on the 
optional task, but a number of laboratories performed functional testing on more samples. Figure 6 
shows qualitative results of the functional testing for all samples with respect to detection of sample 
content. Four approaches delivered correct results on samples S1, S3 and S5, among them two adenine 
release assays (MS, functional) and two cytotoxicity assays (marked by an arrow in Figure 6). The 
successful functional MS-based approaches detected eight out of nine samples correctly as  
ricin-containing material. Sample S7 containing the lowest ricin concentration was not detected by any 
of the functional tests applied. 
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With respect to mass spectrometry-based approaches, different techniques and instrumentations
were used (MALDI-TOF MS, LC-ESI MS). Most laboratories applied a combination of immunoaffinity
enrichment using different antibodies with tryptic digestion and MS or MS/MS detection and
identification (Figure 5). Three approaches delivered correct results on seven or eight out of nine
samples analyzed. These are marked by an arrow in Figure 5.
In contrast to the immunological methods, these successful approaches delivered completely
correct results straightaway—corresponding to color code dark green for S2 to S8—for the majority of
the samples analyzed. Thus, in contrast to immunological assays selected spectrometric approaches
allowed for unambiguous identification of the measurand. However, due to the detection limit of
current MS approaches [51], the detection of sample S7 containing the lowest concentration of ricin
was unsuccessful in this exercise. Selected successful mass spectrometric methods for the detection
and identification of ricin are described in more detail by Kalb et al. in this Special Issue of Toxins [76].
With respect to functional testing, two different types of functional assays were applied by
the laboratories:
(i) a combination of immunoaffinity enrichment plus detection of the depurination activity of ricin or
RCA120 from an artificial substrate (MS-based adenine release assay);
(ii) a cell-based cytotoxicity assay detecting the cell death induced by ricin or RCA120.
As an optional challenge, the PT participants were asked to rank samples S1, S3 and S5 by their
functional activity using the designation “highest”, “intermediate” and “lowest” functional activity.
Therefore, functional assays were preferentially used on samples S1, S3 and S5 in order to work
on the optional task, but a number of laboratories performed functional testing on more samples.
Figure 6 shows qualitative results of the functional testing for all samples with respect to detection
of sample content. Four approaches delivered correct results on samples S1, S3 and S5, among them
two adenine release assays (MS, functional) and two cytotoxicity assays (marked by an arrow in
Figure 6). The successful functional MS-based approaches detected eight out of nine samples correctly
as ricin-containing material. Sample S7 containing the lowest ricin concentration was not detected by
any of the functional tests applied.
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Figure 6. Qualitative results reported as “ricin”, “RCA120” and “ricin and/or RCA120” for all nine
samples displayed by different functional approaches. Laboratories used either functional MS-based
approaches to measure the ricin-induced adenine release by an artificial substrate or different cell
culture-based cytotoxicity assays. Sample S1 was the negative control sample, samples S3, S4, S6–S8
contained ricin, samples S2 and S5 contained RCA120, and S9 was the organic fertilizer containing
Ricinus communis (both ricin and RCA120). Methods marked by an arrow delivered qualitatively
correct results on the samples S1, S3 and S5 which were specifically asked to be ranked by functional
activity (optional task). Qualitative results reported by the participants were color-coded as indicated
in Table 3.
With respect to ranking samples S1, S3 and S5 by their functional activity into “highest”,
“intermediate” and “lowest” functional activity, samples S3 and S5 contained ricin or RCA120,
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respectively, in intermediate concentrations (S3: 522 ng/mL ricin; S5: 481 ng/mL RCA120),
while sample S1 was the negative control. Though the protein concentration of S3 and S5 was
approximately the same, the difference in depurination activity and overall cytotoxicity could be
correctly assigned: in the exercise, five out of six methods applied delivered correct results with
respect to functional activity ranking (Figure 7). Successful protocols for functional testing are
described in more detail in [60,67,68,76].
Based on the qualitative PT results reported by the 17 participating laboratories, good analytical
practices can now be derived. To achieve this, the different technical approaches applied were
grouped together according to their detection principle and statistically analyzed, to provide an
overview of success rates obtained for the different detection principles on all nine samples. This
analysis is useful for drawing some general conclusions on the methods applied, while it is important
to keep in mind that different analytical protocols and tools have been used and that for each detection
principle successful individual strategies have been identified in the PT (Figures 3–6). Additionally,
one should keep in mind that the methods were applied by a variable number of laboratories, so
that statistics should not be overestimated. Table 4 provides an overview of success rates obtained
for the different detection principles on all nine samples. Generally, the success rate of the methods
applied ranged from 71.5%–77.7% when all nine samples were considered corresponding to similar
overall success rates for the different methods (Table 4). At first sight, this outcome is different to
results obtained in a parallel PT on botulinum toxin detection that was performed in the framework
of EQuATox and is reviewed in Worbs et al. [77]: for this toxin, a set of methods was identified that
resulted in higher success rates than other methods.Toxins 2015, 7 14 
 
 
 
Figure 7. Results reported for the ranking of specified samples S1, S3 and S5 according to 
their functional activity by different methods. Laboratories used either functional  
MS-based approaches to measure the ricin-induced adenine release by an artificial 
substrate or different cell culture-based cytotoxicity assays. Sample S3 contained ricin and 
showed the highest functional activity; S5 contained RCA120 and had intermediate 
activity; S1 was the negative control sample without detectable functional activity. Results 
of ranking according functional activity reported by the participants were color-coded with 
blue “sample activity ranked correctly” and red “wrong ranking of sample activity”. 
Table 4. Qualitative results of methods used for ricin detection: overview of success rates 
obtained for different methods on all samples *. Numbers in bold highlight the total 
percentage of correct results (= sum of correct positive and correct negative results). 
Main Assay  
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Laboratories 
Correct Results % Total % 
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Method 
ELISA 103 7 
correct positive 64.1 
77.7 
correct negative 13.6 
On-site detection (LFA, pTD) 165 10 
correct positive 60.6 
71.5 
correct negative 10.9 
MS-Based  
Method 
MS detection 117 8 
correct positive 42.7 
73.5 
correct negative 30.8 
Functional  
Method 
Functional MS assay (Adenine release) 29 4 
correct positive 62.1 
75.9 
correct negative 13.8 
Cytotoxicity assay 35 4 
correct positive 51.4 
74.3 
correct negative 22.9 
* Detailed classification of success rates for the different methods applied for ricin detection. For each 
method the total number of results reported per method is indicated, the number of laboratories applying an 
individual method and the percentage of correct positive or correct negative results. 
However, a more detailed analysis of ricin PT results considering individual samples allowed us to 
draw further conclusions (Table 5). To this end, mean success rates for different technical approaches 
were calculated for individual samples containing ricin or RCA120 in equivalent concentrations (e.g., 
comparison of samples S6 and S2 containing high concentrations of ricin or RCA120, respectively, 
and samples S3 and S5 containing intermediate concentrations of ricin or RCA120, respectively; Table 5). 
In this approach, the different immunological methods (e.g., ELISA, pTD and LFA; Figures 3 and 4) 
Figure 7. Results reported for the ranking of specified samples S1, S3 and S5 according to their
functional activity by different methods. Laboratories used either functional MS-based approaches
to measure the ricin-induced adenine release by an artificial substrate or different cell culture-based
cytotoxicity ass ys. Sample S3 contained ricin and showed th highest functional activity; S5
contained RCA120 and had intermediate activity; S1 was the negative control sample without
detectable functional activity. Results of ranking according functional activity reported by the
participants were color-coded with blue “sample activity ranked correctly” and red “wrong ranking
of sample activity”.
However, a more detailed analysis of ricin PT results considering individual samples allowed
us to draw further conclusions (Table 5). To this end, mean success rates for different technical
approaches were calculated for individual samples containing ricin or RCA120 in equivalent
concentrations (e.g., comparison of samples S6 and S2 containing high concentrations of ricin
or RCA120, respectively, and samples S3 and S5 containing intermediate concentrations of ricin
or RCA120, respectively; Table 5). In this approach, the different immunological methods
(e.g., ELISA, pTD and LFA; Figures 3 and 4) were grouped together; similarly, the MS-based methods
targeting sample identity—but not functional activity—were grouped together (e.g., MALDI-TOF MS
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and LC-MS/MS; Figure 5); finally, functional approaches were grouped together (e.g., cytotoxicity
assay, functional MS assay; Figure 6; similar classification as in Table 4). As shown in Table 5,
this comparative analysis helped to visualize advantages and limitations of different technical
approaches. Comparing samples containing high concentrations of either ricin (S6) or RCA120 (S2),
mass spectrometric approaches delivered superior results with success rates of 79%–87% indicating
that these methods are best suited for differentiation of the highly homologous proteins. A mixed
picture was obtained at intermediate concentrations with no clear trends for different technical
approaches: ricin detection was achieved at similar success rates (50%–63%) using immunological,
MS-based and functional approaches, with a tendency that MS-based and functional methods are
somewhat better suited for the correct assignment of RCA120. At low ricin concentrations, however,
immunological methods clearly delivered the highest success rates (21% compared to success rates
of 0%–8% for functional and MS-based approaches); this is most probably linked to their higher
sensitivity especially in conventional ELISA-formats (Figure 3; [38,42,43,51,74,78]).
Table 4. Qualitative results of methods used for ricin detection: overview of success rates obtained for
different methods on all samples *. Numbers in bold highlight the total percentage of correct results
(= sum of correct positive and correct negative results).
Main Assay
Principle Method
Total Number of
Results
Number of
Laboratories Correct Results % Total %
Immunological
Method
ELISA 103 7
correct positive 64.1
77.7correct negative 13.6
On-site detection
(LFA, pTD) 165 10
correct positive 60.6
71.5correct negative 10.9
MS-Based
Method MS detection 117
8
correct positive 42.7
73.5correct negative 30.8
Functional
Method
Functional MS assay
(Adenine release) 29 4
correct positive 62.1
75.9correct negative 13.8
Cytotoxicity assay 35 4
correct positive 51.4
74.3correct negative 22.9
* Detailed classification of success rates for the different methods applied for ricin detection. For each method
the total number of results reported per method is indicated, the number of laboratories applying an individual
method and the percentage of correct positive or correct negative results.
Table 5. Mean success rates given in percent obtained for different technical approaches on selected
samples for analytes “ricin” or “RCA120” *.
Main Assay Principle # S6 Ricinhigh(588,949 ng/mL)
S2 RCA120high
(563,994 ng/mL)
S3 Ricinintermediate
(522 ng/mL)
S5 RCA120intermediate
(481 ng/mL)
S7 Ricinlow
(0.441 ng/mL)
Immunol. method 71 43 63 27 21
MS-based method 87 79 50 39 8
Functional method 43 57 54 42 0
* Analyte concentration and sample number as indicated in the Table header. # Grouping of methods: ELISA,
LFA and pTD results were grouped into “immunological method”, MALDI-TOF MS and LC-MS/MS results
into “MS-based method” and cytotoxicity assay and functional MS assay into “functional method”.
This analysis might be helpful to decide which methods can be used and combined in
order to get preliminary, confirmed, and unambiguous results on a ricin-containing sample. In
this context, it is of particular note that several laboratories delivered correct results on all nine
samples by combining different analytical approaches (i.e., immunological, MS-based and functional
methods) while individual laboratories were successful by combining different highly sophisticated
MS approaches targeting both protein identity and functional activity of ricin. With respect to
good analytical practices this information will be crucial in the future to develop recommended
operating procedures and optimized workflows for the analysis of toxin-containing samples that are
supported internationally.
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2.2.2. Quantitative Results of the Ricin Proficiency Test
Independent of the qualitative reporting, the participating laboratories were asked to perform
quantification of ricin in the nine samples and to report the results of two independent measurements
in a dedicated Excel reporting file. Again, for quantification any method established and validated in
the laboratories was admitted; if the laboratories planned to use different methods for quantification,
they were asked to submit results in separate quantitative reporting sheets. In this context, some
basic questions were asked regarding the scope of assay validation performed prior to the PT
(e.g., detection limit of the method, coefficients of variation and measurement uncertainty) and
the reference material used. The quantitative measurements reported by the participants were—as
far as possible—evaluated statistically according to the recommendations by Thompson et al. and
Algorithm A of the international standard ISO 13528:2005 “Statistical methods for use in proficiency
testing by inter-laboratory comparisons” [71,79].
Quantification of ricin in the PT samples was performed by 14 of 17 participating laboratories
(some reported results as measurand “ricin”, others as measurands “ricin and/or RCA120”; only
results reported as “ricin” are considered here). Most laboratories used classical ELISA-based
methods for quantification, one laboratory used an MS-based approach (please see [42,76] for
details). In order to assess and visualize quantitative results, z-scores were calculated according to
the equation.
z “ x´ xa
σp
(1)
with x denoting the results reported by the participants, xa the assigned concentration value, and
σp the standard deviation for proficiency assessment, respectively (Table 2). z-scores (in the context
of PTs) quantify the difference between an individual single or mean result and the assigned value
in units of the standard deviation for proficiency assessment. This transformation is known as
standardization; the standardized dataset has a mean of zero (0) and a standard deviation (and
variance) of one (1) if xa and σp are the respective statistics of the empirical distribution of the
data considered. A z-score of zero indicates an unbiased result with respect to the assigned value,
a z-score of 1 is one standard deviation for proficiency assessment above the assigned value, a z-score
of ´1 is one standard deviation for proficiency assessment below the assigned value and so on.
Provided that the data points are realizations of normally distributed random variables with mean
xa and standard deviation σp (i.e., x ~N(xa, σp2)), this is the model to which the results reported are
compared, the z-scores represent realizations of random variables of the standard normal distribution
(i.e., z ~N(0, 1)) where about 95% of z-scores will fall between ´2 and +2 (the sign “´” or “+” of
the score indicates a negative or positive deviation, respectively). According to Thompson et al. [71],
scores in this range are commonly designated “acceptable” or “satisfactory”. Scores in the ranges
´2 to ´3 and +2 to +3 would be expected about once in 20, and scores in this class are sometimes
designated “questionable”. A score outside the range from ´3 to +3 would be very unusual
and is taken to indicate that the cause of the event should be investigated and remedied, and
Thompson et al. [71] suggest the phrase “requiring action” for such results.
Exemplarily, the quantitative results provided by the participants for sample S6 containing the
highest concentration of ricin in buffer is visualized in Figure 8 as normal probability plot of z-scores.
z-scores of normally distributed concentration values with sample statistics xa and σp2 would lie
along a straight line with slope 1 in these plots. Normal probability plots are used to display both the
dispersion of a dataset and the deviation of the empirical distribution from statistical normality. As
can be seen in Figure 8, most of the quantitative data of sample S6 approximately followed the normal
distribution of the model x ~N(xa, σp2), only a single value was far off. Notably, all but one z-score
obtained by the participants on sample S6 were close to zero. This was independent of the methods
used for quantification—ELISA or MS-based method—and the individual reference material used in
the laboratories. Seven quantitative results reported lay within the interval´2 < z < +2 corresponding
to satisfactory results (Figure 8). Therefore, the mean of participants’ quantitative results for S6 as
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estimated by robust statistics was defined as consensus concentration of the ricin reference material
generated in [69] and used to spike PT samples in this exercise.
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Figure 8. Normal probability plot of z-scores for quantification of ricin in sample S6. Standard 
normal quantiles were plotted against the z-scores to visualize if scores (representing 
concentrations reported) were normally distributed. The analysis was done by considering all 
methods used to quantify the indicated sample. Each dot corresponds to one method used by 
one laboratory; some laboratories used more than one method for quantification. 
In order to evaluate the methods used for quantification of ricin the accordance of methods was 
assessed based on the quantitative results reported and the calculated z-scores. Figure 9 shows the  
z-score means (points and figures) and their standard deviations (error bars span mean ± SD) as 
computed from the z-scores. The z-score means offer a guide to assess the mean closeness of a method 
to the assigned concentration if applied by a number of laboratories to a number of samples, and the 
corresponding standard deviation measures the variation of the z-scores among the respective samples 
and laboratories. N indicates the number of z-scores available for each method analyzed (please note 
that the number of available z-scores is variable). The analysis summarized in Figure 9 was performed 
by considering quantitative results reported for all samples in the PT. 
The various classical ELISA formats used in this PT showed a good mean trueness (trueness in the 
sense of comparability of methods) with a z-score mean of −0.1 for all samples (n = 59, Figure 9) and  
a z-score mean of +0.1 when only sample S6 was considered (n = 12; not shown); furthermore, a good 
agreement of z-scores among the samples and laboratories corresponding to a small standard deviation 
was observed. Taking into account that different ELISA-formats based on different antibodies and 
different ricin reference materials were used in the laboratories, the quantitative results obtained by 
ELISAs indicate the superiority of this methodology. 
For LFA and MS-based methods, less z-scores were available for this analysis, so caution has to be 
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used for quantification than ELISA showed larger deviations from the assigned values (z-scores > 2.5) 
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Figure 8. Normal probability plot of z-scores for quantification of ricin in sample S6. Standard normal
quantiles were plotted against the z-scores to visualize if scores (representing concentrations reported)
were normally distributed. The analysis was done by considering all methods used to quantify the
indic ted sample. Each dot corresponds to one method us d by one laboratory; some laborato ies
used more than one method for quantification.
In order to evaluate the methods used for quantification of ricin the accordance of methods
was assessed based on the quantitative results reported and the calculated z-scores. Figure 9 shows
the z-score means (points and figures) and their standard deviations (error bars span mean ˘ SD) as
computed from the z-scores. The z-score means offer a guide to assess the mean closeness of a method
to th as igned concentration if applied by a number of laboratories to a number of sa ples, and
the corresponding standard deviation measures the variation of the z-scores among the respective
samples and laboratories. N indicates the number of z-scores available for each method analyzed
(please note that the number of available z-scores is variable). The analysis summarized in Figure 9
was performed by considering quantitative results reported for all samples in the PT.Toxins 2015, 7 18 
 
 
 
Figure 9. Accordance of methods. z-score means (points and figures) and their standard 
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were purchased from a local retail store. Milk was opened under sterile conditions and spiked with a 
defined amount of ricin or RCA120 as indicated in Table 1. A particle-free meat extract was prepared 
by extracting 10 g of minced meat from pork and beef (1:1) with 90 mL of gelatin phosphate buffer 
(pH 6). The meat was removed by centrifugation and the supernatant was autoclaved, filtrated and 
spiked with a defined amount of toxin as indicated above. In parallel, buffer (0.1% BSA/PBS pH 7) 
was spiked with toxin as indicated in Table 1. All spiked samples were analyzed and quantitated for 
their ricin or RCA120 concentration by sandwich ELISA without any further sample preparation 
(Section 3.2). For sample S9 an organic fertilizer naturally contaminated with R. communis shred was 
used that was involved in a case of dog poisoning in Germany [3]: to extract and quantify toxins 
contained in the fertilizer 2 g of the sample were extracted with 20 mL PBS (pH 7) for 2 h by rotating 
at room temperature. Supernatant was collected by centrifugation and quantification of ricin and 
RCA120 in this material was performed as described in Section 3.2. 
3.2. Amplified Sandwich ELISAs for Ricin and RCA120 
The ELISA specific for ricin was performed as described before in Pauly et al. [38,42]. Briefly, 
MaxiSorp microtiter plates (Thermo Fisher Scientific, Rockford, USA) were coated with 5 µg/mL of 
capture mAb R109 in 50 µL PBS overnight at 4 °C. Blocking was performed with casein buffer 
(Senova, Jena, Germany) for 1 h at room temperature. After a washing step, 50 µL of toxin-containing 
solution was added: (i) either serial dilutions of ricin reference material (an in-house purified ricin 
preparation, independently prepared of the material described in [69]) starting from 100 ng/mL to  
0.05 pg/mL in assay buffer (PBS, 0.1% BSA (Sigma-Aldrich, Munich, Germany)) as standard curve; 
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The various classical ELISA formats used in this PT showed a good mean trueness (trueness
in the sense of comparability of methods) with a z-score mean of ´0.1 for all samples (n = 59,
Figure 9) and a z-score mean of +0.1 when only sample S6 was considered (n = 12; not shown);
furthermore, a good agreement of z-scores among the samples and laboratories corresponding to
a small standard deviation was observed. Taking into account that different ELISA-formats based
on different antibodies and different ricin reference materials were used in the laboratories, the
quantitative results obtained by ELISAs indicate the superiority of this methodology.
For LFA and MS-based methods, less z-scores were available for this analysis, so caution has to be
taken to draw general conclusions. Available data could be interpreted in the way that other methods
used for quantification than ELISA showed larger deviations from the assigned values (z-scores > 2.5)
and less accordance between the z-scores among samples and laboratories (high standard deviation;
Figure 9). However, this effect might well be related to the reference material used and might be
independent of the methods itself. This question should be further evaluated in future exercises.
3. Experimental Section
3.1. Preparation of PT Samples
As complex food matrices ultra-high temperature (UHT) semi-skimmed milk and minced meat
were purchased from a local retail store. Milk was opened under sterile conditions and spiked with a
defined amount of ricin or RCA120 as indicated in Table 1. A particle-free meat extract was prepared
by extracting 10 g of minced meat from pork and beef (1:1) with 90 mL of gelatin phosphate buffer
(pH 6). The meat was removed by centrifugation and the supernatant was autoclaved, filtrated and
spiked with a defined amount of toxin as indicated above. In parallel, buffer (0.1% BSA/PBS pH 7)
was spiked with toxin as indicated in Table 1. All spiked samples were analyzed and quantitated
for their ricin or RCA120 concentration by sandwich ELISA without any further sample preparation
(Section 3.2). For sample S9 an organic fertilizer naturally contaminated with R. communis shred was
used that was involved in a case of dog poisoning in Germany [3]: to extract and quantify toxins
contained in the fertilizer 2 g of the sample were extracted with 20 mL PBS (pH 7) for 2 h by rotating
at room temperature. Supernatant was collected by centrifugation and quantification of ricin and
RCA120 in this material was performed as described in Section 3.2.
3.2. Amplified Sandwich ELISAs for Ricin and RCA120
The ELISA specific for ricin was performed as described before in Pauly et al. [38,42]. Briefly,
MaxiSorp microtiter plates (Thermo Fisher Scientific, Rockford, USA) were coated with 5 µg/mL
of capture mAb R109 in 50 µL PBS overnight at 4 ˝C. Blocking was performed with casein buffer
(Senova, Jena, Germany) for 1 h at room temperature. After a washing step, 50 µL of toxin-containing
solution was added: (i) either serial dilutions of ricin reference material (an in-house purified ricin
preparation, independently prepared of the material described in [69]) starting from 100 ng/mL
to 0.05 pg/mL in assay buffer (PBS, 0.1% BSA (Sigma-Aldrich, Munich, Germany)) as standard
curve; or (ii) diluted samples (dilution in PBS + 0.1% BSA). Samples were incubated for 2 h at
room temperature. Detection was performed by incubation with biotin-labelled secondary antibody
diluted in casein buffer (1 h, room temperature), followed by a washing step and detection with
Streptavidin-PolyHRP40 conjugate (0.5 ng/mL, Senova, Jena, Germany). After a washing step the
sandwich ELISA was developed by adding 100 µL of substrate solution 3,31,5,51-tetramethylbenzidine
(TMB; SeramunBlau slow, Seramun Diagnostika, Heidesee, Germany). Reaction was stopped by
100 µL of 0.25 M acid sulfur.
The ELISA for RCA120 was performed similarly using mAb ARK4 as capture antibody (kindly
provided by Marc-André Avondet, Spiez Laboratory, Switzerland; [80]) and biotinylated polyclonal
chicken IgY RC22 [81] as detection antibody. As reference material for quantification the highly
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purified RCA120 described in [69] was used. Further information on the performance of both ELISA
is given in [69].
3.3. Stability and Homogeneity Testing, Nominal Concentration
In order to demonstrate sample stability during the PT test period (set to four weeks), ten aliquots
of each sample S1 to S9 were prepared by spiking of the matrices with ricin or RCA120 as indicated in
Table 1 and used prior to the actual PT for stability testing. Five aliquots were stored for four weeks
at ´80 ˝C, and five aliquots were stored for four weeks at 4 ˝C for comparison (for a total number
of 90 aliquots). After storage at the indicated condition the samples were frozen at ´80 ˝C until
analysis. All sample sets were analyzed simultaneously on a single day by the ELISA corresponding
to the measurand contained in a sample: (i) an ELISA detecting ricin for samples S3, S4 and S6–S9;
and (ii) an ELISA detecting RCA120 for samples S2, S5 and S9 (Section 3.2).
For analysis, all ricin-containing samples were diluted to a concentration of 0.1 ng/mL which
is in the linear range of the respective ELISA close to the EC50 value. Along the same line,
for the RCA120-ELISA samples containing RCA120 were diluted to a concentration of 0.5 ng/mL
before analysis.
For statistical analysis of the ELISA results, two outlying values were identified by Grubbs tests
(R and R package “outliers”) and excluded from the fitting of linear models with storage conditions
as fixed effects and post hoc Dunnett tests with storage condition 4 w/´80 ˝C as control group, using
SYSTAT 13 [82–84].
For homogeneity testing, 33 aliquots of each sample S1 to S9 were prepared as before, and
ten randomly selected aliquots were used for homogeneity testing. Homogeneity of each test
material was assessed according to Thompson et al. [71] and ISO/IEC 17043:2012 [70] on the basis of
absorbance values at 450 nm obtained by sandwich ELISA. The ten randomly selected test aliquots of
each sample were analyzed in duplicate in two independent experiments using the ELISA detecting
ricin or RCA120, respectively. The ELISAs were performed as described in Section 3.2. Statistically,
Cochran tests were performed to assess the homogeneity of variances; duplicates with outlying
variances were excluded. As the data structure was more complex than described in Thompson et al.
and therefore not suitable for the standard statistical procedure recommended in [71], factorial
linear mixed models were set up to fit the data and to provide estimates of the sampling standard
deviations and the analytical standard deviations, respectively, using SYSTAT 13 [83]. These variance
components were assessed according to Thompson et al. [71], Recommendations 7 and 8.
In order to determine the nominal concentrations of the samples three aliquots of each
sample S1–S9 were measured in duplicate in independent experiments on three days. The
ELISAs were performed as described in Section 3.2. Extreme values were not excluded for
the analysis; instead, the analytical results were evaluated by the robust algorithm according to
ISO 5725-5:1998 and ISO 13528:2005 Annex C (using R package “metrology”) to compute the nominal
concentrations [72,79,85]. For the determination of assigned values and the decision rule used please
see Section 2.1 and Table 2.
3.4. Statistical Analysis and Data Visualization
Qualitative responses (categories “1”–“5”, indicating 1 = ricin, 2 = RCA120, 3 = ricin AND/OR
RCA120, 4 = negative result and 5 = not analyzed) were compared to the correct answers by simple
algorithms. For dichotomic grouping (correct/false) it was sufficient to introduce auxiliary variables
using codes 1 and 0, respectively; codes for more differentiated evaluations were either multi-valued
or built from the dichotomic codes. On the basis of these categorical auxiliary variables the success
rates were obtained by frequency tabulation or by computing the means of the auxiliary variables
grouped by the categories of interest (e.g., grouped by method). The resulting data tables were
exported from SYSTAT to Excelr and color-coded by conditional color formatting of each cell of
the auxiliary variables.
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The quantitative measurements reported by the participants were statistically evaluated
according to the recommendations of Thompson et al. and Algorithm A of the international standard
ISO 13528:2005 [79]. Statistical evaluations were performed using SYSTAT 13 and R (libraries
“metRology” and “outliers”) [82,83,85].
Robust algorithms of the R package “metrology” were used to compute the assigned
concentrations. z-scores were obtained on the basis of these assigned values (Table 2) and the
respective standard deviations for proficiency assessment (see Section 2.1). Normal probability plots
of the z-scores were produced by commercial software (SYSTAT 13; Figure 8: GraphPad Prism 5)
in order to visualize the empirical distributions of the results reported, as compared to the model
implicitly set as normal distribution with mean xa and variance σp2 (i.e., x ~N(xa, σp2)). Assessment
of the accordance of methods was based on the arithmetic means of the individual z-scores as shown
in Figure 9.
4. Conclusions
Ricin is recognized as a dual-use substance: On the one hand the ricin-producing plant is of
economic interest for the production of castor oil and the numerous products produced using the
oil. On the other hand, the ricin toxin, a byproduct of castor oil production, has a known history of
military, criminal and terroristic misuse [21,28–34]. In addition, accidental intoxications in humans
and animals have been reported [3]. The toxin is a list 1-compound under the CWC, therefore
handling of ricin requires special attention and is strictly controlled by national and international
authorities. The security and health concerns require the rapid detection, precise identification and
accurate quantification of ricin in order to enable appropriate management decisions. Currently
expert laboratories use different technologies for the detection and identification of ricin based on
immunological, spectrometric or functional approaches, but hardly any universally agreed “gold
standards” are available, including common internationally recognized reference materials, widely
accessible tools, or accepted standard operating procedures. Differently purified in-house materials of
variable quality are used in expert laboratories for validation purposes, making a direct comparison of
accuracy, sensitivity, and specificity of different methods nearly impossible. Additionally, no regular
training and self-evaluation possibilities such as PTs or ring trials on dedicated methods have been
available in the past. In this respect the situation is clearly different from other scientific areas, e.g.,
the food sector, where regular demonstration of technical performance by proficiency testing or ring
trials is generally accepted to accompany appropriate standardization efforts and to ensure technical
competence. As examples, several proficiency tests and/or ring trials were performed in the food
sector to test detection capabilities for low molecular weight toxins such as aflatoxins, mycotoxins and
paralytic shellfish poisoning toxins, as well as high molecular weight toxins such as staphylococcal
enterotoxins [86–90].
Against this background, the aim of the ricin PT conducted in the framework of the EQuATox
project was to provide an overview and evaluation of existing methods for screening, detection,
identification, and quantification of ricin among 17 participating laboratories from EU-28 and
beyond. Nine samples were selected to test for sensitivity (different concentrations of ricin in buffer),
specificity (differentiation of corresponding concentrations of ricin and the highly homologous
RCA120) as well as matrix interference (spiked food matrices and a naturally contaminated organic
fertilizer material [3]). A variety of methods were used by the participants, combining different
detection principles. Qualitative results reported by the participants were analyzed by the different
methods applied and the degree of trueness of the participants’ assignments.
Immunological methods applied included seven classical ELISA formats, six LFA formats
and the pTD platform [44], the latter two technologies were tested as rapid on-site detection
approaches. Four out of seven classical sandwich ELISA delivered correct results on all nine samples.
Notably, these ELISA were able to detect sample S7 containing the lowest ricin concentration,
which did cause difficulties when analyzed by other technical approaches. Detection of ricin in the
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low pg/mL range is relevant in the context of human ricin intoxications (own unpublished data
and [91]). While the ELISA-based methods were not suitable for unambiguous identification of
ricin, they were most sensitive to detect ricin-containing samples in the low pg/mL range which
is usually not covered by other approaches. The pTD instrument as well as three LFA turned
out to be suitable screening approaches to detect “dangerous”, ricin-containing samples within
20 min, albeit at reduced sensitivity compared to laboratory-based ELISA (eight out of nine samples
identified correctly), the latter point is in accordance with literature data [35–43,73,75,92]. More
detailed information on selected immunological methods is given in this Special Issue of Toxins by
Simon et al. [42].
Common to all immunological methods was the inability to differentiate ricin from the highly
homologous RCA120, a task that might be relevant under certain circumstances (e.g., an OPCW
investigation or a lawsuit). In this context mass spectrometric methods to identify the protein content
proved their ability to unambiguously discriminate between ricin and RCA120: three different
MS-based methods were identified that gave correct results on seven or eight out of nine samples.
Due to their currently limited sensitivity compared to ELISA-based methods, the low-concentration
sample (S7) was not correctly identified [38,42,43,51,74,78]. However, MS-based methods offer the
technical advantage of providing extensive detail about known and unknown sample contents,
especially when using tandem mass spectrometry, thereby adding an open view into the diagnostic or
forensic workflow [33]. Successful MS-based approaches are further described in [76] in this Special
Issue of Toxins.
With respect to functional methods, two general approaches were used in the ricin PT: either a
combination of immunoaffinity enrichment plus detection of the depurination activity of ricin from
an artificial substrate (MS-based adenine release assay), or a cell-based cytotoxicity assay detecting
the cell death induced by ricin. Two protocols each allowed to identify functionally active ricin
or RCA120 and to rank three specified samples according to their functional activity. Successful
protocols for functional testing are described in more detail in [60,67,68,76]. One of these approaches
has been successfully applied in an extensive public health investigation following a “white powder”
discovery in a hotel room in Las Vegas, USA, in 2008 [33]. In this context, functional methods are
important to evaluate the potential danger associated with a suspect sample, thus providing decision
makers with valuable information necessary to initiate appropriate countermeasures.
Generally, with respect to good analytical practices identified in the PT, it turned out that either
laboratories combining different analytical approaches (i.e., immunological, MS-based and functional
methods) or laboratories applying highly sophisticated MS-based approaches targeting both protein
identity and functional activity of ricin delivered superior results. Depending on the laboratories’
requirements appropriate methods need to be selected: exemplarily, the analysis of clinical samples
requires highest sensitivity while detection of functional activity is less important. On the other
hand, in the course of a forensic investigation, it might be most important to unambiguously identify
the sample as ricin based on mass spectrometry including information on purity and activity of
the material found. Along this line, good analytical strategies identified in this exercise used a
combination of (i) highly sensitive sandwich ELISA for detection; and (ii) either LC-MS/MS or
MALDI TOF MS/MS confirmation; and (iii) either an cell-based cytotoxicity assay or an MS-based
adenine-release assay to highlight the functional activity of the samples. In line with Bozza et al.
ricin-containing samples should ideally be detected and identified taking into account the biological
activity of ricin’s A and B chain. Such a comprehensive analysis helps to evaluate any potential
risk associated with a suspect sample and allows taking appropriate management decisions [93].
The information obtained in this PT allows future development of optimized workflows and
recommended operating procedures for the analysis of ricin-containing samples—ideally this effort
should be undertaken in the context of a consolidated international EQuATox network with broad
expert support by different nations and standardization bodies.
5004
Toxins 2015, 7, 4987–5010
With respect to quantification of ricin, several ELISA-based methods and one MS-based
approach were applied. z-scores were used to evaluate the reported quantitative results according
to [71,79]. Quantitative results reported by different ELISA-formats used in this PT showed a
good mean trueness with a z-score mean of ´0.1 for all samples. Furthermore, when evaluating
results reported on highly concentrated sample S6, seven quantitative results lay within the interval
´2 < z < +2 corresponding to satisfactory results. Therefore, the mean of participants’ quantitative
results for S6 as estimated by robust statistics was defined as consensus concentration of the ricin
reference material generated in [69] and used to spike PT samples in this exercise. To the best of our
knowledge, this material represents the only in-depth-characterized ricin reference material available
with a consensus concentration defined in an international PT. The results obtained provide a basis
for further steps in quality assurance and set the basis for development of certified reference materials
in the future.
The cornerstones of the next developments in the process of harmonization of analytical
approaches would be to make accessible highly specific tools (mainly antibodies for extraction
purposes), to thoroughly validate analytical procedures and to agree upon recommended standard
operating procedures. Furthermore, further technical improvement with respect to sensitivity and
specificity of some of the methods used as well as sample preparation strategies should be addressed.
It can be expected that the detection limit is severely influenced or compromised in different complex
matrices. Depending on the scenario and the sample under analysis, low concentrations of ricin
would be expected—this is especially true for clinical samples. Finally, organizing regular proficiency
tests with an increasing level of difficulty as well as ring trials on dedicated techniques will bring
forward the process of harmonization and standardization and will help to keep the vigilance high.
Acknowledgments: The research leading to any result within the EQuATox project has received funding from
the European Community’s Seventh Framework Program (FP7/2007-2013) under grant agreement no. 285120
which is greatly acknowledged by the authors and participants.
All participating laboratories are kindly acknowledged for their expert contribution to the exercise and for
providing their results: Crister Astot, Swedish Defence Research Agency (FOI), Sweden; Marc-André Avondet,
SPIEZ Laboratory, Switzerland; John Barr, Centers for Disease Control and Prevention (CDC), USA; Hsiao Ying
Chen, Defence Science Organisation National Laboratories, Singapore; Cindi Corbett, Public Health Agency of
Canada, Canada; Christophe Creminon, French Alternative Energies and Atomic Energy Commission (CEA),
France; Martin Dorner, Robert Koch Institute, Germany; Michael Drevinek, National Institute for Nuclear,
Chemical and Biological Protection, Czech Republic; Frank Gessler, miprolab GmbH, Germany; Zoltan Kis,
National Center for Epidemiology, Hungary; Isabel Lopes de Carvalho, Ana Pelerito, Rita Cordeiro and Sofia
Núncio, Instituto Nacional de Saúde Ricardo Jorge, Portugal; Jaran Strand Olsen, Norwegian Defence Research
Establishment, Norway; Julia Riehm, Institut für Mikrobiologie der Bundeswehr, Germany; Sylvia Schirmer,
Bundeswehr Research Institute for Protective Technologies—NBC-Protection, Germany; Martin Söderström,
VERIFIN, Finland; Francois Thibault, Military Biomedical Research Institute, France; Didrik Frimann Vestrheim,
Norwegian Institute of Public Health, Norway.
We are grateful for the expert support by Kathrin Grunow and Olena Shatohina (Robert Koch
Institute, Germany).
Author Contributions: Designed, performed experiments and interpreted data: S.W., M.S., J.B., and B.G.D.
Performed statistical analysis: W.L. Contributed technical and statistical expertise: R.Z. and H.S. Wrote the
manuscript: S.W., B.G.D., R.Z., H.S. and W.L.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Stillmark, H. Über Ricin, ein giftiges Fragment aus den Samen von Ricinus comm. L und einigen anderen
Euphorbiaceen. Ph.D. Thesis, Kaiserliche Universität zu Dorpat (University of Tartu), Tartu, Estonia,
February 1888.
2. Lappi, D.A.; Kapmeyer, W.; Beglau, J.M.; Kaplan, N.O. The disulfide bond connecting the chains of ricin.
Proc. Natl. Acad. Sci. USA 1978, 75, 1096–1100. [CrossRef] [PubMed]
3. Worbs, S.; Köhler, K.; Pauly, D.; Avondet, M.A.; Schaer, M.; Dorner, M.B.; Dorner, B.G. Ricinus communis
intoxications in human and veterinary medicine—A summary of real cases. Toxins 2011, 3, 1332–1372.
[CrossRef] [PubMed]
5005
Toxins 2015, 7, 4987–5010
4. Baenziger, J.U.; Fiete, D. Structural determinants of Ricinus communis agglutinin and toxin specificity for
oligosaccharides. J. Biol. Chem. 1979, 254, 9795–9799. [PubMed]
5. Olsnes, S.; Saltvedt, E.; Pihl, A. Isolation and comparison of galactose-binding lectins from Abrus precatorius
and Ricinus communis. J. Biol. Chem. 1974, 249, 803–810. [PubMed]
6. Sandvig, K.; van Deurs, B. Endocytosis and intracellular transport of ricin: Recent discoveries. FEBS Lett.
1999, 452, 67–70. [CrossRef]
7. Lord, J.; Roberts, L.; Robertus, J. Ricin: Structure, mode of action, and some current applications. FASEB J.
1994, 8, 201–208. [CrossRef] [PubMed]
8. Sweeney, E.C.; Tonevitsky, A.G.; Temiakov, D.E.; Agapov, I.I.; Saward, S.; Palmer, R.A. Preliminary
crystallographic characterization of ricin agglutinin. Proteins Struct. Funct. Bioinform. 1997, 28, 586–589.
[CrossRef]
9. Roberts, L.M.; Lamb, F.I.; Pappin, D.J.; Lord, J.M. The primary sequence of Ricinus communis agglutinin.
Comparison with ricin. J. Biol. Chem. 1985, 260, 15682–15686. [PubMed]
10. Brandt, N.N.; Chikishev, A.Y.; Sotnikov, A.I.; Savochkina, Y.A.; Agapov, I.I.; Tonevitskii, A.G.;
Kirpichnikov, M.P. Conformational difference between ricin and ricin agglutinin in solution and crystal.
Dokl. Biochem. Biophys. 2001, 376, 26–28. [CrossRef] [PubMed]
11. Saltvedt, E. Structure and toxicity of pure ricinus agglutinin. Biochim. Biophys. Acta 1976, 451, 536–548.
[CrossRef]
12. Araki, T.; Funatsu, G. The complete amino acid sequence of the B-chain of ricin E isolated from small-grain
castor bean seeds. Ricin E is a gene recombination product of ricin D and Ricinus communis agglutinin.
Biochim. Biophys. Acta 1987, 911, 191–200. [CrossRef]
13. Ladin, B.F.; Murray, E.E.; Halling, A.C.; Halling, K.C.; Tilakaratne, N.; Long, G.L.; Houston, L.L.;
Weaver, R.F. Characterization of a cDNA encoding ricin E, a hybrid ricin-Ricinus communis agglutinin gene
from the castor plant Ricinus communis. Plant Mol. Biol. 1987, 9, 287–295. [CrossRef] [PubMed]
14. Mise, T.; Funatsu, G.; Ishiguro, M.; Funatsu, M. Isolation and characterization of ricin E from castor beans.
Agric. Biol. Chem. 1977, 41, 2041–2046. [CrossRef]
15. Chan, A.P.; Crabtree, J.; Zhao, Q.; Lorenzi, H.; Orvis, J.; Puiu, D.; Melake-Berhan, A.; Jones, K.M.;
Redman, J.; Chen, G.; et al. Draft genome sequence of the oilseed species Ricinus communis. Nat. Biotechnol.
2010, 28, 951–956. [CrossRef] [PubMed]
16. Leshin, J.; Danielsen, M.; Credle, J.J.; Weeks, A.; O’Connell, K.P.; Dretchen, K. Characterization of ricin toxin
family members from Ricinus communis. Toxicon 2010, 55, 658–661. [CrossRef] [PubMed]
17. Despeyroux, D.; Walker, N.; Pearce, M.; Fisher, M.; McDonnell, M.; Bailey, S.C.; Griffiths, G.D.; Watts, P.
Characterization of ricin heterogeneity by electrospray mass spectrometry, capillary electrophoresis, and
resonant mirror. Anal. Biochem. 2000, 279, 23–36. [CrossRef] [PubMed]
18. Sehgal, P.; Khan, M.; Kumar, O.; Vijayaraghavan, R. Purification, characterization and toxicity profile of
ricin isoforms from castor beans. Food Chem. Toxicol. 2010, 48, 3171–3176. [CrossRef] [PubMed]
19. Sehgal, P.; Kumar, O.; Kameswararao, M.; Ravindran, J.; Khan, M.; Sharma, S.; Vijayaraghavan, R.;
Prasad, G.B.K.S. Differential toxicity profile of ricin isoforms correlates with their glycosylation levels.
Toxicology 2011, 282, 56–67. [CrossRef] [PubMed]
20. Bergström, T.; Fredriksson, S.Å.; Nilsson, C.; Åstot, C. Deamidation in ricin studied by capillary zone
electrophoresis- and liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed.
Life Sci. 2015, 974, 109–117. [CrossRef] [PubMed]
21. Ogunniyi, D.S. Castor oil: A vital industrial raw material. Bioresour. Technol. 2006, 97, 1086–1091. [CrossRef]
[PubMed]
22. Strebhardt, K.; Ullrich, A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat. Rev. Cancer 2008,
8, 473–480. [CrossRef] [PubMed]
23. Tyagi, N.; Tyagi, M.; Pachauri, M.; Ghosh, P.C. Potential therapeutic applications of plant toxin-ricin in
cancer: Challenges and advances. Tumour Biol. 2015. [CrossRef] [PubMed]
24. Frankel, A.E.; Woo, J.H.; Neville, D.M. Principles of Cancer Biotherapy, 5th ed.; Springer: Dodrecht, The
Netherland, 2009.
5006
Toxins 2015, 7, 4987–5010
25. Schindler, J.; Gajavelli, S.; Ravandi, F.; Shen, Y.; Parekh, S.; Braunchweig, I.; Barta, S.; Ghetie, V.; Vitetta, E.;
Verma, A. A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in
adult patients with refractory B-lineage acute lymphoblastic leukaemia. Br. J. Haematol. 2011, 154, 1–6.
[CrossRef] [PubMed]
26. Spitler, L.E.; del Rio, M.; Khentigan, A.; Wedel, N.I.; Brophy, N.A.; Miller, L.L.; Harkonen, W.S.;
Rosendorf, L.L.; Lee, H.M.; Mischak, R.P.; et al. Therapy of Patients with Malignant Melanoma Using
a Monoclonal Antimelanoma Antibody-Ricin A Chain Immunotoxin. Cancer Res. 1987, 47, 1717–1723.
[PubMed]
27. Zhou, X.X.; Ji, F.; Zhao, J.L.; Cheng, L.F.; Xu, C.F. Anti-cancer activity of anti-p185HER-2 ricin A chain
immunotoxin on gastric cancer cells. J. Gastroenterol. Hepatol. 2010, 25, 1266–1275. [CrossRef] [PubMed]
28. Audi, J.; Belson, M.; Patel, M.; Schier, J.; Osterloh, J. Ricin poisoning: A comprehensive review. J. Am. Med.
Assoc. 2005, 294, 2342–2351. [CrossRef] [PubMed]
29. Franz, D.R.; Jaax, N.K. Ricin toxin. In Medical Aspects of Chemical and Biological Warfare; Sidell, F.R.,
Takafuji, E.T., Franz, D.R., Eds.; TMM Publications: Washington, DC, USA, 1997; pp. 631–642.
30. Kirby, R. Ricin toxin: A military history. CML Army Chem. Rev. 2004, 304, 38–40.
31. Zilinskas, R.A. Iraq’s biological weapons. J. Am. Med. Assoc. 1997, 278, 418–424. [CrossRef]
32. Moran, G.J. Threats in bioterrorism. II: CDC category B and C agents. Emerg. Med. Clin. N. Am. 2002, 20,
311–330. [CrossRef]
33. Schieltz, D.M.; McGrath, S.C.; McWilliams, L.G.; Rees, J.; Bowen, M.D.; Kools, J.J.; Dauphin, L.A.;
Gomez-Saladin, E.; Newton, B.N.; Stang, H.L.; et al. Analysis of active ricin and castor bean proteins in
a ricin preparation, castor bean extract, and surface swabs from a public health investigation. Forensic Sci.
Int. 2011, 209, 70–79. [CrossRef] [PubMed]
34. Hayden, E.C.; Wadman, M. US ricin attacks are more scary than harmful. Nat. News 2013. [CrossRef]
35. Alderton, M.R.; Paddle, B. A sensitive enzyme linked immunosorbent assay (ELISA) for the detection of
ricin in blood. DSTO Aeronaut. Mar. Res. Lab. 1997, 9, 1–12.
36. Gaylord, S.T.; Dinh, T.L.; Goldman, E.R.; Anderson, G.P.; Ngan, K.C.; Walt, D.R. Ultrasensitive detection of
ricin toxin in multiple sample matrixes using single-domain antibodies. Anal. Chem. 2015, 87, 6570–6577.
[CrossRef] [PubMed]
37. Leith, A.G.; Griffiths, G.D.; Green, M.A. Quantification of ricin toxin using a highly sensitive avidin/biotin
enzyme-linked immunosorbent assay. J. Forensic Sci. Soc. 1988, 28, 227–236. [CrossRef]
38. Pauly, D.; Kirchner, S.; Stoermann, B.; Schreiber, T.; Kaulfuss, S.; Schade, R.; Zbinden, R.; Avondet, M.A.;
Dorner, M.B.; Dorner, B.G. Simultaneous quantification of five bacterial and plant toxins from complex
matrices using a multiplexed fluorescent magnetic suspension assay. Analyst 2009, 134, 2028–2039.
[CrossRef] [PubMed]
39. Griffiths, G.D.; Newman, H.; Gee, D.J. Identification and quantification of ricin toxin in animal tissues using
ELISA. J. Forensic Sci. Soc. 1986, 26, 349–358. [CrossRef]
40. Shyu, H.F.; Chiao, D.J.; Liu, H.W.; Tang, S.S. Monoclonal antibody-based enzyme immunoassay for
detection of ricin. Hybrid. Hybridomics 2002, 21, 69–73. [CrossRef] [PubMed]
41. Shyu, R.H.; Shyu, H.F.; Liu, H.W.; Tang, S.S. Colloidal gold-based immunochromatographic assay for
detection of ricin. Toxicon 2002, 40, 255–258. [CrossRef]
42. Simon, S.; Worbs, S.; Avondet, M.A.; Tracz, D.M.; Dano, J.; Volland, H.; Dorner, B.G.; Corbett, C.R.
Recommended immunological assays to screen for ricin-containing samples. Toxins 2015, 7. [CrossRef]
43. Thullier, P.; Griffiths, G. Broad recognition of ricin toxins prepared from a range of Ricinus cultivars using
immunochromatographic tests. Clin. Toxicol. 2009, 47, 643–650. [CrossRef] [PubMed]
44. Portable Toxin Detector. Available online: https://www.bruker.com/de/products/cbrne-detection/elisa/
ptd/ overview.html (accessed on 13 October 2015).
45. Narang, U.; Anderson, G.P.; Ligler, F.S.; Burans, J. Fiber optic-based biosensor for ricin. Biosens. Bioelectron.
1997, 12, 937–945. [CrossRef]
46. Zhuang, J.; Cheng, T.; Gao, L.; Luo, Y.; Ren, Q.; Lu, D.; Tang, F.; Ren, X.; Yang, D.; Feng, J.; et al. Silica coating
magnetic nanoparticle-based silver enhancement immunoassay for rapid electrical detection of ricin toxin.
Toxicon 2010, 55, 145–152. [CrossRef] [PubMed]
5007
Toxins 2015, 7, 4987–5010
47. Brinkworth, C.S.; Pigott, E.J.; Bourne, D.J. Detection of intact ricin in crude and purified extracts from
castor beans using matrix-assisted laser desorption ionization mass spectrometry. Anal. Chem. 2009, 81,
1529–1535. [CrossRef] [PubMed]
48. Dupre, M.; Gilquin, B.; Fenaille, F.; Feraudet-Tarisse, C.; Dano, J.; Ferro, M.; Simon, S.; Junot, C.; Brun, V.;
Becher, F. Multiplex Quantification of Protein Toxins in Human Biofluids and Food Matrices Using
Immunoextraction and High-Resolution Targeted Mass Spectrometry. Anal. Chem. 2015, 87, 8473–8480.
[CrossRef] [PubMed]
49. Fredriksson, S.Å.; Artursson, E.; Bergström, T.; Östin, A.; Nilsson, C.; Åstot, C. Identification of RIP-II
toxins by affinity enrichment, enzymatic digestion and LC-MS. Anal. Chem. 2015, 87, 967–974. [CrossRef]
[PubMed]
50. Fredriksson, S.-Å.; Hulst, A.G.; Artursson, E.; de Jong, A.L.; Nilsson, C.; van Baar, B.L. Forensic
identification of neat ricin and of ricin from crude castor bean extracts by mass spectrometry. Anal. Chem.
2005, 77, 1545–1555. [CrossRef] [PubMed]
51. McGrath, S.C.; Schieltz, D.M.; McWilliams, L.G.; Pirkle, J.L.; Barr, J.R. Detection and quantification of ricin
in beverages using isotope dilution tandem mass spectrometry. Anal. Chem. 2011, 83, 2897–2905. [CrossRef]
[PubMed]
52. Norrgran, J.; Williams, T.L.; Woolfitt, A.R.; Solano, M.I.; Pirkle, J.L.; Barr, J.R. Optimization of digestion
parameters for protein quantification. Anal. Biochem. 2009, 393, 48–55. [CrossRef] [PubMed]
53. Östin, A.; Bergström, T.; Fredriksson, S.Å.; Nilsson, C. Solvent-assisted trypsin digestion of ricin for forensic
identification by LC-ESI MS/MS. Anal. Chem. 2007, 79, 6271–6278. [CrossRef] [PubMed]
54. Bevilacqua, V.L.; Nilles, J.M.; Rice, J.S.; Connell, T.R.; Schenning, A.M.; Reilly, L.M.; Durst, H.D. Ricin
activity assay by direct analysis in real time mass spectrometry detection of adenine release. Anal. Chem.
2010, 82, 798–800. [CrossRef] [PubMed]
55. Hale, M.L. Microtiter-based assay for evaluating the biological activity of ribosome-inactivating proteins.
Pharmacol. Toxicol. 2001, 88, 255–260. [CrossRef] [PubMed]
56. He, X.; Lu, S.; Cheng, L.W.; Rasooly, R.; Carter, J.M. Effect of food matrices on the biological activity of ricin.
J. Food Prot. 2008, 71, 2053–2058. [PubMed]
57. Hines, H.B.; Brueggemann, E.E.; Hale, M.L. High-performance liquid chromatography-mass selective
detection assay for adenine released from a synthetic RNA substrate by ricin A chain. Anal. Biochem.
2004, 330, 119–122. [CrossRef] [PubMed]
58. Keener, W.K.; Rivera, V.R.; Young, C.C.; Poli, M.A. An activity-dependent assay for ricin and related
RNA N-glycosidases based on electrochemiluminescence. Anal. Biochem. 2006, 357, 200–207. [CrossRef]
[PubMed]
59. Langer, M.; Rothe, M.; Eck, J.; Mockel, B.; Zinke, H. A nonradioactive assay for ribosome-inactivating
proteins. Anal. Biochem. 1996, 243, 150–153. [CrossRef] [PubMed]
60. Pauly, D.; Worbs, S.; Kirchner, S.; Shatohina, O.; Dorner, M.B.; Dorner, B.G. Real-time cytotoxicity assay
for rapid and sensitive detection of ricin from complex matrices. PLoS ONE 2012, 7, e35360. [CrossRef]
[PubMed]
61. Roday, S.; Sturm, M.B.; Blakaj, D.; Schramm, V.L. Detection of an abasic site in RNA with stem-loop DNA
beacons: Application to an activity assay for Ricin Toxin A-Chain. J. Biochem. Biophys. Methods 2008, 70,
945–953. [CrossRef] [PubMed]
62. Vang, O.; Larsen, K.P.; Bøg-Hansen, T.C. A new quantitative and highly specific assay for lectinbinding
activity. In Lectins; Walter de Gruyter & Co.: Berlin, Germany, 1986; Volume 6, pp. 637–644.
63. Brzezinski, J.L.; Craft, D.L. Evaluation of an in vitro bioassay for the detection of purified ricin and castor
bean in beverages and liquid food matrices. J. Food Prot. 2007, 70, 2377–2382. [PubMed]
64. Colombatti, M.; Johnson, V.G.; Skopicki, H.A.; Fendley, B.; Lewis, M.S.; Youle, R.J. Identification and
characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
J. Immunol. 1987, 138, 3339–3344. [PubMed]
65. Halter, M.; Almeida, J.L.; Tona, A.; Cole, K.D.; Plant, A.L.; Elliott, J.T. A mechanistically relevant cytotoxicity
assay based on the detection of cellular GFP. Assay Drug Dev. Technol. 2009, 7, 356–365. [CrossRef] [PubMed]
66. Oda, T.; Komatsu, N.; Muramatsu, T. Cell lysis induced by ricin D and ricin E in various cell lines.
Biosci. Biotechnol. Biochem. 1997, 61, 291–297. [CrossRef] [PubMed]
5008
Toxins 2015, 7, 4987–5010
67. Becher, F.; Duriez, E.; Volland, H.; Tabet, J.C.; Ezan, E. Detection of functional ricin by immunoaffinity and
liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79, 659–665. [CrossRef] [PubMed]
68. Kalb, S.R.; Barr, J.R. Mass spectrometric detection of ricin and its activity in food and clinical samples.
Anal. Chem. 2009, 81, 2037–2042. [CrossRef] [PubMed]
69. Worbs, S.; Skiba, M.; Söderström, M.; Rapinoja, M.L.; Zeleny, R.; Russmann, H.; Schimmel, H.; Vanninen, P.;
Fredriksson, S.-Å.; Dorner, B.G. Characterization of Ricin and R. communis Agglutinin Reference Materials.
Toxins 2015, 7. [CrossRef]
70. International Organization for Standardization. ISO/IEC 17043 Conformity Assessment—General Requirements for
Proficiency Testing; International Organization for Standardization: Geneva, Switzerland, 2010.
71. Thompson, M.; Ellison, S.L.R.; Wood, R. The International Harmonized Protocol for the proficiency testing
of analytical chemistry laboratories (IUPAC Technical Report). Pure Appl. Chem. 2006, 78, 145–196.
[CrossRef]
72. International Organization for Standardization. ISO 5725–5 Accuracy (Trueness and Precision) of Measurement
Methods and Results—Part 5: Alternative Methods for the Determination of the Precision of a Standard
Measurement Method; International Organization for Standardization: Geneva, Switzerland, 1998.
73. Slotved, H.C.; Sparding, N.; Tanassi, J.T.; Steenhard, N.R.; Heegaard, N.H. Evaluating 6 ricin field detection
assays. Biosecur. Bioterror. 2014, 12, 186–189. [CrossRef] [PubMed]
74. Weber, M.; Schulz, H. Immunological detection of ricin and castor seeds in beverages, food and consumer
products. Toxichem. Krimtech. 2011, 78, 276–277.
75. Hodge, D.R.; Prentice, K.W.; Ramage, J.G.; Prezioso, S.; Gauthier, C.; Swanson, T.; Hastings, R.;
Basavanna, U.; Datta, S.; Sharma, S.K.; et al. Comprehensive laboratory evaluation of a highly
specific lateral flow assay for the presumptive identification of ricin in suspicious white powders and
environmental samples. Biosecur. Bioterror. 2013, 11, 237–250. [CrossRef] [PubMed]
76. Kalb, S.R.; Schieltz, D.M.; Becher, F.; Astot, C.; Fredriksson, S.Å.; Barr, J.R. Recommended Mass
Spectrometry-Based Strategies to Identify Ricin-Containing Samples. Toxins 2015, 7. [CrossRef] [PubMed]
77. Worbs, S.; Fiebig, U.; Zeleny, R.; Schimmel, H.; Rummel, A.; Luginbühl, W.; Dorner, B.G. Qualitative and
quantitative detection of botulinum neurotoxins from complex matrices: Results of the first international
proficiency test. Toxins 2015, 7. [CrossRef]
78. Garber, E.A.; O'Brien, T.W. Detection of ricin in food using electrochemiluminescence-based technology.
J. AOAC Int. 2008, 91, 376–382. [PubMed]
79. International Organization for Standardization. ISO 13528 Statistical Methods for Use in Proficiency Testing
by Interlaboratory Comparisons; International Organization for Standardization: Geneva, Switzerland, 2005;
pp. 1–76.
80. Popova, E.N. Interaction between Ricin and Hybridoma Cells Secreting Antibodies Specific for the Catalytic
Subunit; Lomonosov Moscow State University: Moscow, Russia, 2004. (In Russian)
81. Pauly, D.; Dorner, M.; Zhang, X.; Hlinak, A.; Dorner, B.; Schade, R. Monitoring of laying capacity,
immunoglobulin Y concentration, and antibody titer development in chickens immunized with ricin and
botulinum toxins over a two-year period. Poult. Sci. 2009, 88, 281–290. [CrossRef] [PubMed]
82. SYSTAT 13; SYSTAT Software Inc. Chicago, IL, USA, 60606. 2010.
83. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical
Computing: Vienna, Austria, 2013.
84. Komsta, Ł. Outliers: Tests for Outliers—A Collection of Some Tests Commonly Used for Identifying
Outliers, R Package: Version 0.14. 2011.
85. Ellison, S.L.R. metRology: Support for Metrological Applications, R Package: Version 0.9-16. 2013.
86. Bianchi, D.M.; Ingravalle, F.; Adriano, D.; Gallina, S.; Gramaglia, M.; Zuccon, F.; Astegiano, S.; Bellio, A.;
Macori, G.; Ru, G.; et al. Reproducibility study for the detection of Staphylococcal enterotoxins in dairy
products between official Italian national laboratories. J. Food Prot. 2014, 77, 999–1004. [CrossRef] [PubMed]
87. Dragacci, S.; Grosso, F.; Pfauwathel-Marchond, N.; Fremy, J.M.; Venant, A.; Lombard, B. Proficiency testing
for the evaluation of the ability of European Union-National Reference laboratories to determine aflatoxin
M1 in milk at levels corresponding to the new European Union legislation. Food Addit. Contam. 2001, 18,
405–415. [CrossRef] [PubMed]
5009
Toxins 2015, 7, 4987–5010
88. Hennekinne, J.A.; Gohier, M.; Maire, T.; Lapeyre, C.; Lombard, B.; Dragacci, S. First proficiency testing
to evaluate the ability of European Union National Reference Laboratories to detect staphylococcal
enterotoxins in milk products. J. AOAC Int. 2003, 86, 332–339. [PubMed]
89. Van Egmond, H.P.; Jonker, K.M.; Poelman, M.; Scherpenisse, P.; Stern, A.G.; Wezenbeek, P.; Bergwerff, A.A.;
Van den Top, H.J. Proficiency studies on the determination of paralytic shellfish poisoning toxins in
shellfish. Food Addit. Contam. 2004, 21, 331–340. [CrossRef] [PubMed]
90. Vongbuddhapitak, A.; Trucksess, M.W.; Atisook, K.; Suprasert, D.; Horwitz, W. Laboratory proficiency
testing of aflatoxins in corn and peanuts—A cooperative project between Thailand and the United States.
J. AOAC Int. 1999, 82, 259–263. [PubMed]
91. Kopferschmitt, J.; Flesch, F.; Lugnier, A.; Sauder, P.; Jaeger, A.; Mantz, J.M. Acute voluntary intoxication by
ricin. Hum. Toxicol. 1983, 2, 239–242. [CrossRef] [PubMed]
92. Guglielmo-Viret, V.; Splettstoesser, W.; Thullier, P. An Immunochromatographic test for the diagnosis of
ricin inhalational poisoning. Clin. Toxicol. 2007, 45, 505–511. [CrossRef] [PubMed]
93. Bozza, W.P.; Tolleson, W.H.; Rosado, L.A.; Zhang, B. Ricin detection: Tracking active toxin. Biotechnol. Adv.
2015, 33, 117–123. [CrossRef] [PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open
access article distributed under the terms and conditions of the Creative Commons by
Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
5010
